Real-time electronic tracking of diarrheal episodes and laxative therapy enables verification of Clostridium difficile clinical testing criteria and reduction of Clostridium difficile infection rates

Journal of Clinical Microbiology

Volumn 55, Issue 5, 2017, Pages 1276-1284

  Truong, Cynthia Y ^a   Gombar, Saurabh ^a   Wilson, Richard ^b   Sundararajan, Gopalakrishnan ^b   Tekic, Natasa ^b   Holubar, Marisa ^a,b   Shepard, John ^b   Madison, Alexandra ^b   Tompkins, Lucy ^a,b   Shah, Neil ^a   Deresinski, Stan ^a,b   Schroeder, Lee F ^c   Banaei, Niaz ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Clostridium difficile; Data tracking; Evidence based medicine; Verification

Indexed keywords

LAXATIVE; METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; BACTERIAL COLONIZATION; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DIARRHEA; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; REAL TIME TRACKING SYSTEM; CROSS INFECTION; DRUG EFFECTS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HOSPITAL INFORMATION SYSTEM; INFORMATION PROCESSING; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES;

AGED; ANTI-BACTERIAL AGENTS; AUTOMATIC DATA PROCESSING; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EVIDENCE-BASED MEDICINE; FEMALE; HOSPITAL INFORMATION SYSTEMS; HUMANS; LAXATIVES; MALE; METRONIDAZOLE; MIDDLE AGED; VANCOMYCIN;

EID: 85018339961     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02319-16     Document Type: Article

References (30)

1. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC. 2015. Burden of Clostridium difficile infection in the United States. N Engl J Med 372: 825-834. https://doi.org/10.1056/NEJMoa1408913.
2. Desai K, Gupta SB, Dubberke ER, Prabhu VS, Browne C, Mast TC. 2016. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach. BMC Infect Dis 16:303. https://doi.org/10.1186/s12879-016-1610-3.
3. Alasmari F, Seiler SM, Hink T, Burnham CA, Dubberke ER. 2014. Prevalence and risk factors for asymptomatic Clostridium difficile carriage. Clin Infect Dis 59:216-222. https://doi.org/10.1093/cid/ciu258.
4. Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. 1990. Nosocomial Clostridium difficile colonisation and disease. Lancet 336:97-100. https://doi.org/10.1016/0140-6736(90)91605-A.
5. Leekha S, Aronhalt KC, Sloan LM, Patel R, Orenstein R. 2013. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. Am J Infect Control 41:390-393. https://doi.org/10.1016/j.ajic.2012.09.023.
6. Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Melvin ZA, Karchmer AW. 1994. Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 18:181-187. https://doi.org/10.1093/clinids/18.2.181.
7. Brazier JS, Fitzgerald TC, Hosein I, Cefai C, Looker N, Walker M, Bushell AC, Rooney P. 1999. Screening for carriage and nosocomial acquisition of Clostridium difficile by culture: a study of 284 admissions of elderly patients to six general hospitals in Wales. J Hosp Infect 43:317-319. https://doi.org/10.1016/S0195-6701(99)90431-0.
8. Hutin Y, Casin I, Lesprit P, Welker Y, Decazes JM, Lagrange P, Modai J, Molina JM. 1997. Prevalence of and risk factors for Clostridium difficile colonization at admission to an infectious diseases ward. Clin Infect Dis 24:920-924. https://doi.org/10.1093/clinids/24.5.920.
9. Kyne L, Warny M, Qamar A, Kelly CP. 2000. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 342:390-397. https://doi.org/10.1056/NEJM200002103420604.
10. Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, Beliveau C, Oughton M, Brukner I, Dascal A. 2011. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 365: 1693-1703. https://doi.org/10.1056/NEJMoa1012413.
11. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31:431-455. https://doi.org/10.1086/651706.
12. Crobach MJ, Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM, Wilcox MH, Kuijper EJ. 2016. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 22(Suppl 4): S63-S81. https://doi.org/10.1016/j.cmi.2016.03.010.
13. Dubberke ER, Han Z, Bobo L, Hink T, Lawrence B, Copper S, Hoppe-Bauer J, Burnham CA, Dunne WM, Jr. 2011. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol 49:2887-2893. https://doi.org/10.1128/JCM.00891-11.
14. Banaei N, Anikst V, Schroeder LF. 2015. Burden of Clostridium difficile infection in the United States. N Engl J Med 372:2368-2369. https://doi.org/10.1056/NEJMc1505190#SA2.
15. Guerrero DM, Chou C, Jury LA, Nerandzic MM, Cadnum JC, Donskey CJ. 2011. Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin. Clin Infect Dis 53:287-290. https://doi.org/10.1093/cid/cir361.
16. Buckel WR, Avdic E, Carroll KC, Gunaseelan V, Hadhazy E, Cosgrove SE. 2015. Gut check: Clostridium difficile testing and treatment in the molecular testing era. Infect Control Hosp Epidemiol 36:217-221. https://doi.org/10.1017/ice.2014.19.
17. Peterson LR, Manson RU, Paule SM, Hacek DM, Robicsek A, Thomson RB, Jr, Kaul KL. 2007. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis 45:1152-1160. https://doi.org/10.1086/522185.
18. Anikst VE, Gaur RL, Schroeder LF, Banaei N. 2016. Organism burden, toxin concentration, and lactoferrin concentration do not distinguish between clinically significant and nonsignificant diarrhea in patients with Clostridium difficile. Diagn Microbiol Infect Dis 84:343-346. https://doi.org/10.1016/j.diagmicrobio.2015.11.022.
19. Polage CR, Solnick JV, Cohen SH. 2012. Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis 55:982-989. https://doi.org/10.1093/cid/cis551.
20. Sickbert-Bennett EE, DiBiase LM, Willis TM, Wolak ES, Weber DJ, Rutala WA. 2016. Reduction of healthcare-associated infections by exceeding high compliance with hand hygiene practices. Emerg Infect Dis 22: 1628-1630. https://doi.org/10.3201/eid2209.151440.
21. Longtin Y, Paquet-Bolduc B, Gilca R, Garenc C, Fortin E, Longtin J, Trottier S, Gervais P, Roussy JF, Levesque S, Ben-David D, Cloutier I, Loo VG. 2016. Effect of detecting and isolating Clostridium difficile carriers at hospital admission on the incidence of C difficile infections: a quasi-experimental controlled study. JAMA Intern Med 176:796-804. https://doi.org/10.1001/jamainternmed.2016.0177.
22. Luo RF, Spradley S, Banaei N. 2013. Alerting physicians during electronic order entry effectively reduces unnecessary repeat PCR testing for Clostridium difficile. J Clin Microbiol 51:3872-3874. https://doi.org/10.1128/JCM.01724-13.
23. Otto CC, Shuptar SL, Milord P, Essick CJ, Nevrekar R, Granovsky SL, Seo SK, Babady NE, Martin SC, Tang YW, Pessin MS. 2015. Reducing unnec-essary and duplicate ordering for ovum and parasite examinations and Clostridium difficile PCR in immunocompromised patients by using an alert at the time of request in the order management system. J Clin Microbiol 53:2745-2748. https://doi.org/10.1128/JCM.00968-15.
24. Tacconelli E. 2009. Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings. Curr Opin Infect Dis 22:352-358. https://doi.org/10.1097/QCO.0b013e32832d52e0.
25. Fridkin SK, Edwards JR, Courval JM, Hill H, Tenover FC, Lawton R, Gaynes RP, McGowan JE, Jr; Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project and the National Nosocomial Infections Surveillance (NNIS) System Hospitals. 2001. The effect of vancomycin and thirdgeneration cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 135: 175-183. https://doi.org/10.7326/0003-4819-135-3-200108070-00009.
26. Isaac S, Scher JU, Djukovic A, Jiménez N, Littman DR, Abramson SB, Pamer EG, Ubeda C. 5 October 2016. Short-and long-term effects of oral vancomycin on the human intestinal microbiota. J Antimicrob Chemother https://doi.org/10.1093/jac/dkw383.
27. Clemente JC, Ursell LK, Parfrey LW, Knight R. 2012. The impact of the gut microbiota on human health: an integrative view. Cell 148:1258-1270. https://doi.org/10.1016/j.cell.2012.01.035.
28. Cohen J, Limbago B, Dumyati G, Holzbauer S, Johnston H, Perlmutter R, Dunn J, Nadle J, Lyons C, Phipps E, Beldavs Z, Clark LA, Lessa FC, CDC's Clostridium difficile Infection Surveillance Investigators. 2014. Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States. J Clin Microbiol 52:632-634. https://doi.org/10.1128/JCM.02177-13.
29. Deshpande A, Pasupuleti V, Rolston DD, Jain A, Deshpande N, Pant C, Hernandez AV. 2011. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: a metaanalysis. Clin Infect Dis 53:e81-90. https://doi.org/10.1093/cid/cir505.
30. Truong C, Schroeder LF, Gaur R, Anikst VE, Komo I, Watters C, McCalley E, Kulik C, Pickham D, Lee NJ, Banaei N. 2017. Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing. Diagn Microbiol Infect Dis 87:365-370. https://doi.org/10.1016/j.diagmicrobio.2016.12.014.